October 22, 2014 10:21 PM ET


Company Overview of Aphton Corp.

Company Overview

Aphton Corporation, a clinical stage biopharmaceutical company, engages in the research and development of cancer immunotherapies. It offers products based on its proprietary active immunization, as well as monoclonal antibody technologies. The company’s products include IGN101, a Phase II/III randomized double-blind clinical trial in non small cell lung cancer patients, is a cancer vaccine designed to induce an immune response against epithelial cell adhesion molecule positive tumor cells; IGN311, which completed an open-label dose escalating Phase I trial, is a monoclonal antibody targeting Lewis Y-positive cancer cells; and Insegia, which is under various clinical trials for gastrointesti...

8 Penn Center

1628 JFK Boulevard Suite 2300

Philadelphia, PA 19103

United States

Founded in 1981

66 Employees





Key Executives for Aphton Corp.

Age: 80
Chief Financial Officer
Age: 64
Chief Scientific Officer and Executive Vice President
Age: 52
Vice President and Medical Director for Clinical Trials and Regulatory Affairs - Europe&Asia
Age: 64
Chief Scientific Officer of Igeneon
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Abmaxis, Inc. United States
Hy BioPharma Inc. United States
Collateral Therapeutics Inc. United States
Xenerex Biosciences, Inc. United States
Synostics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aphton Corp., please visit www.aphton.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.